• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    BioStem Technologies Announces the Engagement of Investment Banking Firm Young America Capital for $15 Million Offering.

    Gabrielle Lakusta
    Jan. 26, 2018 09:00AM PST
    Biotech Investing

    BioStem Technologies (OTC PINK: BSEM) announced the engagement of investment banking firm Young America Capital as an advisor for the Company’s upcoming $15 Million Reg D, 506(c) private placement offering. As quoted in the press release: “Over the past year, BioStem Tech has made impressive progress with the completion of our state of the art …

    BioStem Technologies (OTC PINK: BSEM) announced the engagement of investment banking firm Young America Capital as an advisor for the Company’s upcoming $15 Million Reg D, 506(c) private placement offering.
    As quoted in the press release:

    “Over the past year, BioStem Tech has made impressive progress with the completion of our state of the art biotech lab and the launch of our pharmaceutical division” said Henry Van Vurst, the Company’s CEO. “Given that progress, we believe that the time is right to engage an award winning investment banking advisory firm to help us secure the growth capital we need for the next stage of the Company’s development; and YAC’s track record in growth capital funding speaks for itself.”

    Click here to read the full press release.

    private placementgrowth capital
    The Conversation (0)

    Go Deeper

    AI Powered
    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×